BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Thung SN. Histologic findings in recurrent HBV. Liver Transpl 2006;12:S50-3. [DOI: 10.1002/lt.20946] [Cited by in Crossref: 30] [Cited by in F6Publishing: 17] [Article Influence: 1.9] [Reference Citation Analysis]
Number Citing Articles
1 Mani H, Kleiner DE. Liver biopsy findings in chronic hepatitis B. Hepatology 2009;49:S61-71. [PMID: 19399798 DOI: 10.1002/hep.22930] [Cited by in Crossref: 77] [Cited by in F6Publishing: 69] [Article Influence: 5.9] [Reference Citation Analysis]
2 Drebber U, Torbenson M, Wedemeyer I, Dienes H. Aktuelle Aspekte zur Histopathologie im Rahmen der Lebertransplantation. Pathologe 2011;32:113-23. [DOI: 10.1007/s00292-010-1405-z] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
3 Park GC, Hwang S, Ahn CS, Kim KH, Moon DB, Ha TY, Song GW, Jung DH, Shin YW, Kim SH. Analysis of S gene mutation of the hepatitis B virus in adult liver transplant recipients showing resistance to hepatitis B immunoglobulin therapy. Transplant Proc. 2013;45:3047-3051. [PMID: 24157033 DOI: 10.1016/j.transproceed.2013.08.055] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
4 Song DE, Jung D, Hwang S, Park B, Yu E. Characterization of Histopathological Features that Differentiate Hepatitis B Virus Infection from Acute Cellular Rejection. Korean J Pathol 2009;43:535. [DOI: 10.4132/koreanjpathol.2009.43.6.535] [Cited by in Crossref: 3] [Article Influence: 0.2] [Reference Citation Analysis]
5 Demetris A, Crawford JM, Minervini MI, Nalesnik M, Ochoa E, Randhawa P, Sasatomi E, Wu T. Transplantation Pathology of the Liver. Surgical Pathology of the GI Tract, Liver, Biliary Tract, and Pancreas. Elsevier; 2009. pp. 1169-229. [DOI: 10.1016/b978-141604059-0.50047-3] [Cited by in Crossref: 3] [Article Influence: 0.2] [Reference Citation Analysis]
6 Hwang S, Ahn C, Song G, Kim K, Moon D, Oh H, Lim Y, Lee HC, Ha T, Jung D, Chung Y, Lee S. Posttransplantation prophylaxis with primary high-dose hepatitis B immunoglobulin monotherapy and complementary preemptive antiviral add-on: Posttransplantation Hepatitis B Prophylaxis. Liver Transpl 2011;17:456-65. [DOI: 10.1002/lt.22226] [Cited by in Crossref: 29] [Cited by in F6Publishing: 20] [Article Influence: 2.6] [Reference Citation Analysis]
7 Chang K. Hepatitis B Immunology for Clinicians. Clinics in Liver Disease 2010;14:409-24. [DOI: 10.1016/j.cld.2010.05.012] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 0.9] [Reference Citation Analysis]
8 Pollicino T, Cacciola I, Saffioti F, Raimondo G. Hepatitis B virus PreS/S gene variants: pathobiology and clinical implications. J Hepatol. 2014;61:408-417. [PMID: 24801416 DOI: 10.1016/j.jhep.2014.04.041] [Cited by in Crossref: 146] [Cited by in F6Publishing: 149] [Article Influence: 18.3] [Reference Citation Analysis]
9 Meneghin A, Hogaboam CM. Infectious disease, the innate immune response, and fibrosis. J Clin Invest 2007;117:530-8. [PMID: 17332880 DOI: 10.1172/JCI30595] [Cited by in Crossref: 132] [Cited by in F6Publishing: 75] [Article Influence: 8.8] [Reference Citation Analysis]
10 Borthwick LA, Wynn TA, Fisher AJ. Cytokine mediated tissue fibrosis. Biochim Biophys Acta 2013;1832:1049-60. [PMID: 23046809 DOI: 10.1016/j.bbadis.2012.09.014] [Cited by in Crossref: 194] [Cited by in F6Publishing: 188] [Article Influence: 19.4] [Reference Citation Analysis]
11 Rammohan A. Current management & future directions in post-liver transplant recurrence of viral hepatitis. Journal of Liver Transplantation 2021;3:100027. [DOI: 10.1016/j.liver.2021.100027] [Reference Citation Analysis]
12 Drebber U, Dienes H. Transplantationspathologie der Leber. Pathologe 2008;29:84-92. [DOI: 10.1007/s00292-007-0956-0] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
13 Fiel MI, Schiano T. Jaundice developing in a patient with hepatitis C4 months after liver transplantation. Hepatology 2009;49:695-6. [PMID: 19177566 DOI: 10.1002/hep.22785] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
14 Te H, Doucette K. Viral hepatitis: Guidelines by the American Society of Transplantation Infectious Disease Community of Practice. Clin Transplant 2019;33. [DOI: 10.1111/ctr.13514] [Cited by in Crossref: 23] [Cited by in F6Publishing: 19] [Article Influence: 7.7] [Reference Citation Analysis]
15 Jiang Z, Feng X, Zhang W, Gao F, Ling Q, Zhou L, Xie H, Chen Q, Zheng S. Recipient cytotoxic T lymphocyte antigen -4+ 49 G/G genotype is associated with reduced incidence of hepatitis B virus recurrence after liver transplantation among Chinese patients. Liver Int. 2007;27:1202-1208. [PMID: 17919231 DOI: 10.1111/j.1478-3231.2007.01553.x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 8] [Article Influence: 0.4] [Reference Citation Analysis]
16 Oh YJ, Park YM, Hong SP, Shin SK, Ji SI, Kim BH, Park SJ, Hong Z. A YIDD Mutation in a Case of Recurrent Hepatitis B after Liver Transplantation Induced by an S-escape Mutant. Gut Liver 2010;4:253-7. [PMID: 20559531 DOI: 10.5009/gnl.2010.4.2.253] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
17 Petrovic LM. Recurrent diseases following liver transplantation: current concepts. Curr Opin Organ Transplant. 2012;17:293-302. [PMID: 22498649 DOI: 10.1097/MOT.0b013e32835365f6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
18 Lenci I, Tisone G, Di Paolo D, Marcuccilli F, Tariciotti L, Ciotti M, Svicher V, Perno CF, Angelico M. Safety of complete and sustained prophylaxis withdrawal in patients liver-transplanted for HBV-related cirrhosis at low risk of HBV recurrence. J Hepatol. 2011;55:587-593. [PMID: 21251938 DOI: 10.1016/j.jhep.2010.12.036] [Cited by in Crossref: 61] [Cited by in F6Publishing: 51] [Article Influence: 5.5] [Reference Citation Analysis]